skip to main content
Language:
Primo Advanced Search
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search prefilters

Results 1 - 20 of 866  for All Library Resources

Results 1 2 3 4 5 next page
Refined by: New Records: New From Last Month remove resource type: Newsletter Articles remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Andrés Román's gesture that is an example of resilience and professionalism at Nacional
Material Type:
Newsletter Article
Add to My Research

Andrés Román's gesture that is an example of resilience and professionalism at Nacional

CE Noticias Financieras, 2024

CE Noticias Financieras English, Latin America - Distributed by ContentEngine LLC

Digital Resources/Online E-Resources

2
Clinical Trial: Taiwan Registry of Hypertrophic Cardiomyopathy (THIC) Research Synopsis
Material Type:
Newsletter Article
Add to My Research

Clinical Trial: Taiwan Registry of Hypertrophic Cardiomyopathy (THIC) Research Synopsis

US Fed News Service, Including US State News, 2024

Copyright HT Digital Streams Limited Apr 24, 2024

Digital Resources/Online E-Resources

3
Geisinger enrolls first patient in amyloid cardiomyopathy trial
Material Type:
Newsletter Article
Add to My Research

Geisinger enrolls first patient in amyloid cardiomyopathy trial

PR Newswire, 2024

Copyright PR Newswire Association LLC May 10, 2024

Digital Resources/Online E-Resources

4
Arrhythmogenesis in Dilated Cardiomyopathy: Role of Mechano-Electric Coupling
Material Type:
Newsletter Article
Add to My Research

Arrhythmogenesis in Dilated Cardiomyopathy: Role of Mechano-Electric Coupling

MENA Report, 2024

2022 Al Bawaba (Albawaba.com) Provided by SyndiGate Media Inc. (Syndigate.info). ;EISSN: 2219-0112

Digital Resources/Online E-Resources

5
Exercise, New Drug Class Recommended for Management of Hypertrophic Cardiomyopathy
Material Type:
Newsletter Article
Add to My Research

Exercise, New Drug Class Recommended for Management of Hypertrophic Cardiomyopathy

Targeted News Service, 2024

Targeted News Service

Digital Resources/Online E-Resources

6
Mayo Clinic Q A: What is hypertrophic cardiomyopathy?
Material Type:
Newsletter Article
Add to My Research

Mayo Clinic Q A: What is hypertrophic cardiomyopathy?

News Bites - Private Companies, 2024

Copyright News Bites Pty Ltd May 3, 2024

Digital Resources/Online E-Resources

7
INTERNATIONAL PATENT: PROLAIO, INC. FILES APPLICATION FOR "SYSTEM AND METHOD OF TREATMENT OF HYPERTROPHIC CARDIOMYOPATHY"
Material Type:
Newsletter Article
Add to My Research

INTERNATIONAL PATENT: PROLAIO, INC. FILES APPLICATION FOR "SYSTEM AND METHOD OF TREATMENT OF HYPERTROPHIC CARDIOMYOPATHY"

US Fed News Service, Including US State News, 2024

Copyright HT Digital Streams Limited May 1, 2024

Digital Resources/Online E-Resources

8
Cytokinetics Announces Five Presentations Related to Aficamten at the European Society of Cardiology Congress 2024
Material Type:
Newsletter Article
Add to My Research

Cytokinetics Announces Five Presentations Related to Aficamten at the European Society of Cardiology Congress 2024

News Bites - Healthcare & Equipment, 2024

Copyright News Bites Pty Ltd May 16, 2024

Digital Resources/Online E-Resources

9
Press Release: Cytokinetics Announces Start of -2
Material Type:
Newsletter Article
Add to My Research

Press Release: Cytokinetics Announces Start of -2

Dow Jones Institutional News, 2024

Copyright Dow Jones & Company Inc. May 8, 2024

Digital Resources/Online E-Resources

10
Student died of cardiac complication
Material Type:
Newsletter Article
Add to My Research

Student died of cardiac complication

CE Noticias Financieras, 2024

CE Noticias Financieras English, Latin America - Distributed by ContentEngine LLC

Digital Resources/Online E-Resources

11
Clinical Trial: Efficacy and Safety of Thoracoscopic Morrow Surgery in the Treatment of Hypertrophic Obstructive Cardiomyopathy
Material Type:
Newsletter Article
Add to My Research

Clinical Trial: Efficacy and Safety of Thoracoscopic Morrow Surgery in the Treatment of Hypertrophic Obstructive Cardiomyopathy

US Fed News Service, Including US State News, 2024

Copyright HT Digital Streams Limited Apr 30, 2024

Digital Resources/Online E-Resources

12
Cytokinetics Inc Submits Patent Application for Methods for Treating Hypertrophic Cardiomyopathy
Material Type:
Newsletter Article
Add to My Research

Cytokinetics Inc Submits Patent Application for Methods for Treating Hypertrophic Cardiomyopathy

Global IP News. Pharmaceutical Patent News, 2024

Copyright© 2024, Globalipnews.com

Digital Resources/Online E-Resources

13
University of Cincinnati issued patent titled "Methods of Treating Diabetic Cardiomyopathy by Inhibiting Glut1"
Material Type:
Newsletter Article
Add to My Research

University of Cincinnati issued patent titled "Methods of Treating Diabetic Cardiomyopathy by Inhibiting Glut1"

News Bites - Private Companies, 2024

Copyright News Bites Pty Ltd May 15, 2024

Digital Resources/Online E-Resources

14
American Heart Association Inc: Exercise, New Drug Class Recommended for Management of Hypertrophic Cardiomyopathy
Material Type:
Newsletter Article
Add to My Research

American Heart Association Inc: Exercise, New Drug Class Recommended for Management of Hypertrophic Cardiomyopathy

News Bites - Private Companies, 2024

Copyright News Bites Pty Ltd May 11, 2024

Digital Resources/Online E-Resources

15
Mayo Clinic Arizona: Mayo Clinic Q A: What is hypertrophic cardiomyopathy
Material Type:
Newsletter Article
Add to My Research

Mayo Clinic Arizona: Mayo Clinic Q A: What is hypertrophic cardiomyopathy

News Bites - Private Companies, 2024

Copyright News Bites Pty Ltd May 9, 2024

Digital Resources/Online E-Resources

16
INTERNATIONAL PATENT: THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM FILES APPLICATION FOR "GENE THERAPY FOR LEMD2 CARDIOMYOPATHY"
Material Type:
Newsletter Article
Add to My Research

INTERNATIONAL PATENT: THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM FILES APPLICATION FOR "GENE THERAPY FOR LEMD2 CARDIOMYOPATHY"

US Fed News Service, Including US State News, 2024

Copyright HT Digital Streams Limited May 16, 2024

Digital Resources/Online E-Resources

17
Cytokinetics Announces Start of CEDAR-HCM, a Clinical Trial of Aficamten in a Pediatric Population With Symptomatic Obstructive Hypertrophic Cardiomyopathy
Material Type:
Newsletter Article
Add to My Research

Cytokinetics Announces Start of CEDAR-HCM, a Clinical Trial of Aficamten in a Pediatric Population With Symptomatic Obstructive Hypertrophic Cardiomyopathy

News Bites - Healthcare & Equipment, 2024

Copyright News Bites Pty Ltd May 9, 2024

Digital Resources/Online E-Resources

18
INTERNATIONAL PATENT: OHIO STATE INNOVATION FOUNDATION, KRIGMAN, JUDITH FILES APPLICATION FOR "COMPOSITIONS AND METHODS FOR PREVENTING CARDIOMYOPATHY"
Material Type:
Newsletter Article
Add to My Research

INTERNATIONAL PATENT: OHIO STATE INNOVATION FOUNDATION, KRIGMAN, JUDITH FILES APPLICATION FOR "COMPOSITIONS AND METHODS FOR PREVENTING CARDIOMYOPATHY"

US Fed News Service, Including US State News, 2024

Copyright HT Digital Streams Limited May 1, 2024

Digital Resources/Online E-Resources

19
Clinical Trial: Assessment of Cardiac Function, Microvascular Function and Cardiac Perfusion in Different Disease Stages of Hypertrophic Cardiomyopathy
Material Type:
Newsletter Article
Add to My Research

Clinical Trial: Assessment of Cardiac Function, Microvascular Function and Cardiac Perfusion in Different Disease Stages of Hypertrophic Cardiomyopathy

US Fed News Service, Including US State News, 2024

Copyright HT Digital Streams Limited May 6, 2024

Digital Resources/Online E-Resources

20
Press Release: Edgewise Therapeutics Doses First Patient in Phase 2 CIRRUS-HCM Trial of EDG-7500 in Obstructive Hypertrophic Cardiomyopathy (HCM)
Material Type:
Newsletter Article
Add to My Research

Press Release: Edgewise Therapeutics Doses First Patient in Phase 2 CIRRUS-HCM Trial of EDG-7500 in Obstructive Hypertrophic Cardiomyopathy (HCM)

Dow Jones Institutional News, 2024

Copyright Dow Jones & Company Inc. May 6, 2024

Digital Resources/Online E-Resources

Results 1 - 20 of 866  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Searching Remote Databases, Please Wait